The DOI matches its Crossref record.
Relationship Between Cancer of Stomach and the ABO Blood Groups
Open accessAbstract
Chronic opioid receptor (OR) activation by morphine causes distinct cellular adaptations responsible for the development of tolerance. The present study examines the effect of chronic morphine exposure on the ability of high-efficacy agonists to mediate δ-OR (DOR) and μ-OR (MOR) uncoupling and internalization, two regulatory mechanisms contributing to rapid desensitization of OR function. Chronic morphine treatment (1 μm; 72 hr) of DOR carrying neuroblastoma x glioma (NG108-15) hybrid cells, a prototypical model system frequently used to study cellular aspects of opioid tolerance, completely blocked the capacity of [d-Ala2,d-Leu5]enkephalin (DADLE) and etorphine to desensitize opioid-stimulated [35S]GTPγS binding and to mediate DOR internalization. Similar findings were obtained on stably DOR- and MOR-transfected human embryonic kidney (HEK) 293 cells. Chronic morphine treatment also heterologously impaired agonist regulation of non-opioid G-protein-coupled receptors, such as the m4-muscarinic acetylcholine receptor and the brain-type cannabinoid receptor. As a possible underlying mechanism, we found that chronic morphine treatment completely blocked agonist-induced redistribution of β-arrestin1 in both NG108-15 and stably MOR-transfected HEK293 cells. Moreover, attenuation of β-arrestin1 function appears to depend on persistent stimulation of MAP kinase activity during the course of chronic morphine treatment, because coincubation of the cells together with the MAP kinase blocker PD98059 fully restored β-arrestin1 translocation and receptor internalization. These results demonstrate that chronic morphine treatment produces adaptational changes at the β-arrestin1 level, which in turn attenuates agonist-mediated desensitization and internalization of G-protein-coupled receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASE
WOOLF, B. (1955) · Annals of Human Genetics · doi:10.1111/j.1469-1809.1955.tb01348.x · Cited by 2,723
Epidemiology of gastric cancer
Crew, K. D., & Neugut, A. I. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i3.354 · Cited by 2,108
ANKYLOSING SPONDYLITIS AND HL-A 27
Brewerton, D. A., Hart, F. D., Nicholls, A., Caffrey, M., James, D. C. O., & Sturrock, R. D. (1973) · The Lancet · doi:10.1016/s0140-6736(73)91360-3 · Cited by 1,836
Epidemiology of gastric cancer: global trends, risk factors and prevention
Rawla, P., & Barsouk, A. (2019) · Gastroenterology Review · doi:10.5114/pg.2018.80001 · Cited by 1,540
Common and rare variants in multifactorial susceptibility to common diseases
Bodmer, W., & Bonilla, C. (2008) · Nature Genetics · doi:10.1038/ng.f.136 · Cited by 1,131
Gastric cancer: epidemiology, prevention, classification, and treatment
Sitarz, R., Skierucha, M., Mielko, J., Offerhaus, J., Maciejewski, R., & Polkowski, W. (2018) · Cancer Management and Research · doi:10.2147/cmar.s149619 · Cited by 1,026
Amundadottir, L., Kraft, P., Stolzenberg-Solomon, R. Z., Fuchs, C. S., Petersen, G. M., Arslan, A. A., Bueno-de-Mesquita, H. B., Gross, M., Helzlsouer, K., Jacobs, E. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.429 · Cited by 706
Evolutionary Significance of the HL-A System
BODMER, W. F. (1972) · Nature · doi:10.1038/237139a0 · Cited by 515
ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?
Jenkins, P. V., & O’Donnell, J. S. (2006) · Transfusion · doi:10.1111/j.1537-2995.2006.00975.x · Cited by 431
Aird, I., Bentall, H. H., Mehigan, J. A., & Roberts, J. A. F. (1954) · BMJ · doi:10.1136/bmj.2.4883.315 · Cited by 426
Self-citationModerne Probleme der Humangenetik
Vogel, F. (1959) · Ergebnisse der Inneren Medizin und Kinderheilkunde · doi:10.1007/978-3-642-94744-5_2 · Cited by 397
ABO Blood Group and the Risk of Pancreatic Cancer
Wolpin, B. M., Chan, A. T., Hartge, P., Chanock, S. J., Kraft, P., Hunter, D. J., Giovannucci, E. L., & Fuchs, C. S. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp020 · Cited by 395
GENETIC BASIS OF SUSCEPTIBILITY TO VIRAL LEUKÆMOGENESIS
Lilly, F., Boyse, E. A., & Old, L. J. (1964) · The Lancet · doi:10.1016/s0140-6736(64)91043-8 · Cited by 350
Epidemiology of upper gastrointestinal malignancies
CREW, K. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.04.021 · Cited by 323
The ABO blood group system and Plasmodium falciparum malaria
Cserti, C. M., & Dzik, W. H. (2007) · Blood · doi:10.1182/blood-2007-03-077602 · Cited by 320
Clinical approach and treatment of benign and malignant parotid masses, personal experience.
(2011) · Europe PMC (PubMed Central) · Cited by 63
ABO Blood Type and Risk of Peyronie’s Disease in Japanese Males
Mitsui, Y., Kobayashi, H., Yamabe, F., Nakajima, K., & Nagao, K. (2022) · The World Journal of Men's Health · doi:10.5534/wjmh.210126 · Cited by 7
Metadata
- Authors
- Aird, I., Bentall, H. H., & Roberts, J. A. F.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1953-04-11
- Volume
- 1
- Issue
- 4814
- Pages
- 799-801
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2023346038
- Cited by
- 672
- References
- 0
- FWCI
- 16.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.